tradingkey.logo
๎™ผ
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™

Evommune Inc

EVMN
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
22.920USD
+0.165+0.73%
์ข…๊ฐ€ย 05/15, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
689.38M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM
๎™

์ž์„ธํ•œ ๋‚ด์šฉ์€ ํšŒ์‚ฌ

Evommune Inc ์ •๋ณด

๎™Œ
์ข…๋ชฉ ์ฝ”๋“œ - -
ํšŒ์‚ฌ ์ด๋ฆ„- -
์ƒ์žฅ์ผ- -
CEO- -
์ง์› ์ˆ˜- -
์œ ํ˜•- -
ํšŒ๊ณ„ ์—ฐ๋„ ์ข…๋ฃŒ- -
์ฃผ์†Œ- -
๋„์‹œ- -
์ฆ๊ถŒ ๊ฑฐ๋ž˜์†Œ- -
๊ตญ๊ฐ€- -
์šฐํŽธ ๋ฒˆํ˜ธ- -
์ „ํ™”- -
์›น์‚ฌ์ดํŠธ- -
์ข…๋ชฉ ์ฝ”๋“œ - -
์ƒ์žฅ์ผ- -
CEO- -

Evommune Inc์˜ ํšŒ์‚ฌ ์ž„์›์ง„

๎™Œ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Dr. Eugene A. Bauer, M.D.
Dr. Eugene A. Bauer, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
270.82K
-5.22%
Ms. Janice Drew
Ms. Janice Drew
Executive Vice President - Operations
Executive Vice President - Operations
33.32K
-15.23%
Mr. Luis Pena
Mr. Luis Pena
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Benjamin F. (Ben) McGraw, III
Dr. Benjamin F. (Ben) McGraw, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kyle B. Carver, CPA
Mr. Kyle B. Carver, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory S. Moss, Esq.
Mr. Gregory S. Moss, Esq.
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
--
--
Dr. Jeegar P. Patel, Ph.D.
Dr. Jeegar P. Patel, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Francois Beaubien, Ph.D.
Dr. Francois Beaubien, Ph.D.
Director
Director
--
--
Dr. David Eric Cohen, M.D.
Dr. David Eric Cohen, M.D.
Independent Director
Independent Director
--
--
Dr. Derek DiRocco, Ph.D.
Dr. Derek DiRocco, Ph.D.
Independent Director
Independent Director
--
--
๋” ๋ณด๊ธฐ
์ด๋ฆ„
์ด๋ฆ„/์ง์œ„
์ง์œ„
์ฃผ์‹ ๋ณด์œ 
๋ณ€๋™
Dr. Eugene A. Bauer, M.D.
Dr. Eugene A. Bauer, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
270.82K
-5.22%
Ms. Janice Drew
Ms. Janice Drew
Executive Vice President - Operations
Executive Vice President - Operations
33.32K
-15.23%
Mr. Luis Pena
Mr. Luis Pena
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Benjamin F. (Ben) McGraw, III
Dr. Benjamin F. (Ben) McGraw, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kyle B. Carver, CPA
Mr. Kyle B. Carver, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Gregory S. Moss, Esq.
Mr. Gregory S. Moss, Esq.
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
Chief Business and Legal Officer, Corporate Secretary, Chief Compliance Officer
--
--

์ˆ˜์ต ๋ถ„์„

๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.
์‚ฌ์—…๋ณ„
์ง€์—ญ๋ณ„
๊ธฐ์—…์ด ์•„์ง ๊ด€๋ จ ๋ฐ์ดํ„ฐ๋ฅผ ๊ณต๊ฐœํ•˜์ง€ ์•Š์•˜์Šต๋‹ˆ๋‹ค.

์ฃผ์‹ ๋ณด์œ  ํ†ต๊ณ„

๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sun, May 10
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Sun, May 10
์ฃผ์ฃผ
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
EQT Partners AB
14.68%
EQT Life Sciences
13.69%
RA Capital Management, LP
9.70%
Pivotal Bioventure Partners Investment Advisor LLC
5.35%
Andera Partners S.A.S.
5.27%
๊ธฐํƒ€
51.31%
์ฃผ์ฃผ
์ฃผ์ฃผ
๋น„์œจ
EQT Partners AB
14.68%
EQT Life Sciences
13.69%
RA Capital Management, LP
9.70%
Pivotal Bioventure Partners Investment Advisor LLC
5.35%
Andera Partners S.A.S.
5.27%
๊ธฐํƒ€
51.31%
์ฃผ์ฃผ ์œ ํ˜•
์ฃผ์ฃผ
๋น„์œจ
Venture Capital
36.77%
Private Equity
19.95%
Investment Advisor
13.95%
Investment Advisor/Hedge Fund
12.52%
Hedge Fund
8.09%
Individual Investor
4.92%
Corporation
3.07%
Research Firm
0.18%
Bank and Trust
0.09%
๊ธฐํƒ€
0.46%

๊ธฐ๊ด€ ์ฃผ์‹ ๋ณด์œ 

๎™Œ
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Apr 1
๋งˆ์ง€๋ง‰ ์—…๋ฐ์ดํŠธ: Wed, Apr 1
๋ณด๊ณ  ๊ธฐ๊ฐ„
๊ธฐ๊ด€ ์ˆ˜
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
2026Q4
4
12.40M
0.00%
--
2026Q1
87
33.49M
92.97%
+17.08M
2025Q4
14
14.63M
46.41%
+14.63M

์ฃผ์ฃผ ํ™œ๋™

๎™Œ
์ด๋ฆ„
๋ณด์œ  ์ฃผ์‹
๋น„์œจ
๋ณ€๋™
Chg %
๋‚ ์งœ
EQT Partners AB
5.29M
14.68%
+358.68K
+7.28%
Feb 17, 2026
EQT Life Sciences
4.93M
13.69%
+4.93M
--
Nov 07, 2025
RA Capital Management, LP
3.49M
9.7%
+35.87K
+1.04%
Feb 17, 2026
Pivotal Bioventure Partners Investment Advisor LLC
1.93M
5.35%
--
--
Dec 31, 2025
Andera Partners S.A.S.
1.90M
5.27%
--
--
Dec 31, 2025
Nan Fung Life Sciences
1.44M
4%
--
--
Dec 31, 2025
RTW Investments L.P.
1.28M
3.56%
+1.28M
--
Dec 31, 2025
SymBiosis Capital Management, LLC
1.28M
3.56%
--
--
Dec 31, 2025
B Capital Group Management LP
1.10M
3.07%
+1.10M
--
Nov 06, 2025
JP Morgan Asset Management
1.10M
3.06%
+1.10M
--
Dec 31, 2025
๋” ๋ณด๊ธฐ

๊ด€๋ จ ETF

๎™Œ
์ด๋ฆ„
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ฐฐ๋‹น๊ธˆ

๎™Œ
์ง€๋‚œ 5๋…„ ๋™์•ˆ ์ด 0.00 USD์˜ ๋ฐฐ๋‹น๊ธˆ์ด ๋ถ„๋ฐฐ๋˜์—ˆ์Šต๋‹ˆ๋‹ค.
๋‚ ์งœ
๋ฐฐ๋‹น๊ธˆ
๊ธฐ์ค€์ผ
์ง€๊ธ‰์ผ
๋ฐฐ๋‹น๋ฝ์ผ
๋ฐ์ดํ„ฐ ์—†์Œ

์ฃผ์‹ ๋ถ„ํ• 

๎™Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
๋‚ ์งœ
๋ฐฐ๋‹น๋ฝ์ผ
์œ ํ˜•
๋น„์œจ
๋ฐ์ดํ„ฐ ์—†์Œ
KeyAI
๎™